SANUWAVE Health has selected LITHOMED to be the distributor for the company’s orthopedic products in Taiwan.
SANUWAVE Health (OTCQB:SNWV) has selected LITHOMED to be the distributor for the company’s orthopedic products in Taiwan.
As quoted in the press release:
Kevin Richardson II, CEO and Chairman, stated, “SANUWAVE has committed to deliver 3-5 new distribution partners in the second quarter and 7-10 by the end of the year. This is the first step in achieving or beating our targets. The minimum order value of $500,000 and expected order value north of $3 million will propel SANUWAVE to continued strong growth internationally. We are also excited to be able to support our science advisor Dr. Chin-Jen Wang, Professor of Orthopedic Surgery at Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Taiwan.”
André Mouton, V.P. International Sales and Relations of SANUWAVE, stated, “We are very pleased with this new relationship. LITHOMED has a wealth of experience within this specific indication and will be the right fit for our needs within the orthopedic market segment in Taiwan. Their access and relationships with Key Opinion Leaders (KOL’s) will prove to be of immense value for market development and revenue growth. Taiwan is the first country where we shall have a definitive split within our distribution model. We recognize that Orthopedics and Wound Care have a different customer base and the designated distributor needs to address that. We are expecting sales from this region to be well over $500,000, with an expected value north of $3.0 million within the next three years. We have more than 200 of our devices in use in Europe and we are sure the Asia market and usage will progress accordingly. Taiwan will be our second territory within Asia,” concluded André Mouton.